Pure Global AI
ANVISA registration 10387650129Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 10387650129CAPRICORN TECHNOLOGIES DO BRASIL LTDAAALTO SCIENTIFIC, LTD.Risk Class II
Verified
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
View exact technical-name matches →
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
CONTROL FD GLYCOHEMOGLOBIN A1C
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10387650129
Process Number
25351594332202045
CNPJ
02823683000102
Company information
Registration Holder
CAPRICORN TECHNOLOGIES DO BRASIL LTDA
Manufacturer
AALTO SCIENTIFIC, LTD.
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Dec 17, 2020
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650129 and manufactured by AALTO SCIENTIFIC, LTD.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.